https://preprod.pressherald.com/tag/prescription-drugs/page/5

prescription drugs

Published
June 11, 2021

Our View: Maine prescription drug bills offer relief to stressed families

The proposals would help limit the constant price increases, which cost Mainers in more ways than one.
Published
June 10, 2021

Maine Voices: Legislators must take action to keep prescription drug prices in line

Lawmakers should not yield to intimidation from those who profit by jacking up prices on medicines Mainers need.
Published
June 8, 2021

Commentary: Congress should stop rewarding Big Pharma with tax breaks for gouging patients

Maine’s congressional delegation should push to eliminate loopholes that allow this industry to dodge paying its fair share.
Published
May 27, 2021

Legislative panel votes down bill to penalize drug companies for price gouging

The pharmaceutical industry has made it clear that it will sue Maine if the state approves the ‘excessive pricing’ bill, which now goes to the full Legislature.
Published
April 24, 2021

Commentary: We need systemic change to address prescription misuse in Maine

Cleaning out the medicine cabinet for Drug Take Back Day on Saturday will help prevent unintended poisoning and medication diversion.

advertisement

Published
April 13, 2021

Drug take back day scheduled in Falmouth
Published
April 10, 2021

Commentary: Don’t put Maine’s health care decisions in the hands of a third party

L.D. 675 could cost thousands of Maine patients and their families access to the medications that allow them to live fulfilling lives, says the mother of a chronically ill teen.
Published
March 23, 2021

Maine Democrats’ bills aim to hold down prescription drug prices, health care costs

Their 5 bills include proposals to reduce price gouging by pharmaceutical companies and help consumers who have trouble paying for insulin.
Published
October 13, 2020

Drug Take Back Day set for Oct. 24
Published
August 12, 2020

Sen. Libby: Maine stands up to drug companies looking to profit off a crisis

Legislators have passed bills aimed at medication cost control and billing transparency – now we must focus on reining in the price of treating COVID.